[HTML][HTML] Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment

Q Yang, X Wei, B Deng, Z Chang, D Jin, Y Huang… - Neurobiology of …, 2022 - Elsevier
Cerebral small vessel disease (CSVD) is a generic term used for intracranial vascular
disorders caused by the structural changes of cerebral microvessels, including the small …

Sex differences in cognition across aging

BH Lee, JE Richard, RG de Leon, S Yagi… - Sex differences in brain …, 2022 - Springer
Sex and gender differences are seen in cognitive disturbances in a variety of neurological
and psychiatry diseases. Men are more likely to have cognitive symptoms in schizophrenia …

Prefrontal parvalbumin interneurons deficits mediate early emotional dysfunction in Alzheimer's disease

S Shu, SY Xu, L Ye, Y Liu, X Cao, JQ Jia… - …, 2023 - nature.com
Alzheimer's disease (AD) is the most common neurodegenerative disease and has an
insidious onset. Exploring the characteristics and mechanism of the early symptoms of AD …

Vision transformers for the prediction of mild cognitive impairment to Alzheimer's disease progression using mid-sagittal sMRI

GM Hoang, UH Kim, JG Kim - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Background Alzheimer's disease (AD) is one of the most common causes of
neurodegenerative disease affecting over 50 million people worldwide. However, most AD …

[HTML][HTML] Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment

B Besteher, T Rocktäschel, AP Garza… - Brain, Behavior, and …, 2024 - Elsevier
As the heterogeneity of symptoms is increasingly recognized among long-COVID patients, it
appears highly relevant to study potential pathophysiological differences along the different …

Structural and functional connectivity abnormalities of the default mode network in patients with Alzheimer's disease and mild cognitive impairment within two …

B Zhou, X Dou, W Wang, H Yao, F Feng, P Wang… - Methods, 2022 - Elsevier
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by
progressive dementia, and amnestic mild cognitive impairment (aMCI) has been defined as …

[HTML][HTML] Gallic acid and hesperidin elevate neurotransmitters level and protect against oxidative stress, inflammation and apoptosis in aluminum chloride-induced …

BE Ekundayo, TO Obafemi, BA Afolabi… - Pharmacological …, 2022 - Elsevier
Abstract Background/Aim Gallic acid and metformin are plant-derived compounds with
biological effects. The present study aimed to evaluate the protective effect of gallic acid and …

The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment

M Sforza, E Bianchini, D Alivernini, M Salvetti… - Journal of Neural …, 2022 - Springer
The regulation of cerebral blood flow (CBF) is a complex and tightly controlled function
ensuring delivery of oxygen and nutrients and removal of metabolic wastes from brain …

Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β …

A Montero-Calle, R Coronel… - Cellular and Molecular …, 2023 - Springer
Background Alzheimer's disease (AD) is a progressive, chronic, and neurodegenerative
disease, and the most common cause of dementia worldwide. Currently, the mechanisms …

The cognitive impact of light: illuminating ipRGC circuit mechanisms

HL Mahoney, TM Schmidt - Nature Reviews Neuroscience, 2024 - nature.com
Ever-present in our environments, light entrains circadian rhythms over long timescales,
influencing daily activity patterns, health and performance. Increasing evidence indicates …